These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32056186)

  • 61. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
    Zhang X; Eyck BM; Yang Y; Liu J; Chao YK; Hou MM; Hung TM; Pang Q; Yu ZT; Jiang H; Law S; Wong I; Lam KO; van der Wilk BJ; van der Gaast A; Spaander MCW; Valkema R; Lagarde SM; Wijnhoven BPL; van Lanschot JJB; Li Z
    BMC Cancer; 2020 Mar; 20(1):194. PubMed ID: 32143580
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.
    Mitchell KG; Nelson DB; Corsini EM; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Sepesi B; Walsh GL; Bhutani MS; Maru DM; Wu CC; Nguyen QN; Ajani JA; Swisher SG; Hofstetter WL
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31313820
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma.
    Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
    Surg Today; 2024 Jan; 54(1):53-63. PubMed ID: 37225930
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
    Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
    Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus.
    Miyata H; Sugimura K; Motoori M; Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Yasui M; Takahashi H; Wada H; Ohue M; Yano M
    Surgery; 2019 Dec; 166(6):1033-1040. PubMed ID: 31493901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma.
    Murakami Y; Hamai Y; Emi M; Hihara J; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Kimura T; Okada M; Nagata Y
    J Radiat Res; 2018 Sep; 59(5):616-624. PubMed ID: 29939306
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.
    Okamoto H; Taniyama Y; Sakurai T; Heishi T; Teshima J; Sato C; Maruyama S; Ito K; Onodera Y; Konno-Kumagai T; Ishida H; Kamei T
    Esophagus; 2018 Oct; 15(4):281-285. PubMed ID: 29948480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Roles of Pathological Assessments of Frozen Sections in Esophageal Squamous Cell Carcinoma.
    Lam AK
    Methods Mol Biol; 2020; 2129():83-93. PubMed ID: 32056171
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database.
    Yu J; Ouyang W; Li Y; Hu J; Xu Y; Wei Y; Liao Z; Liu Y; Zhang J; Xie C
    Cancer Med; 2019 Jan; 8(1):21-27. PubMed ID: 30561117
    [TBL] [Abstract][Full Text] [Related]  

  • 71. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
    Chang CL; Tsai HC; Lin WC; Chang JH; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Radiother Oncol; 2017 Oct; 125(1):73-79. PubMed ID: 28923576
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
    Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
    Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Koh HK; Park Y; Koo T; Park HJ; Lee MY; Chang AR; Hong S; Bae H
    Anticancer Res; 2020 Mar; 40(3):1771-1778. PubMed ID: 32132086
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Salvage treatment for superficial local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Nagai Y; Yoshida N; Baba H
    Dig Endosc; 2020 Jan; 32(1):146. PubMed ID: 31535391
    [No Abstract]   [Full Text] [Related]  

  • 77. [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].
    Wang YX; Yang Q; He M; Qiu R; Li J; Zhu SC; Qiao XY; Qi Z
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):48-55. PubMed ID: 28104034
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dosimetric Predictors of Radiation Gastritis Due to Postoperative Intensity Modulated Irradiation Therapy in Patients with Esophageal Squamous Cell Carcinoma After Radical Esophagectomy.
    Shen WB; Wang YF; Gao HM; Zhu SC; Li YM; Li SG; Su JW; Li J; Liu ZK
    Cancer Biother Radiopharm; 2019 Sep; 34(7):419-426. PubMed ID: 31149837
    [No Abstract]   [Full Text] [Related]  

  • 80. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.